PAM
PLXP

Panagora Asset Management’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Panagora Asset Management’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,613
Closed -$7K – 2553
2018
Q3 		$7K Sell
1,613
-259
-14% -$974 ﹤0.01% 2334
2018
Q2 		$7K Buy
+1,872
New +$7.64K ﹤0.01% 2295

Other funds holding PLXP

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Panagora Asset Management's PLXP Position: Q4 2018 in Review

Panagora Asset Management sold out of PLx Pharma Inc. Common Stock (PLXP) in Q4 2018, closing a stake of 1,613 shares — an estimated $7K sold.

Panagora Asset Management first reported a position in PLXP in Q2 2018 and held it in 2 quarters. The position peaked at $7K in Q3 2018. 14 funds tracked by Wall St. Rank hold PLXP as of Q4 2018.

  • Panagora Asset Management reported no remaining PLx Pharma Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Panagora Asset Management sold 1,613 PLx Pharma Inc. Common Stock shares in Q4 2018, an estimated $7K.
  • Panagora Asset Management first reported a position in PLx Pharma Inc. Common Stock in Q2 2018 and held it in 2 quarters.
  • Panagora Asset Management's PLx Pharma Inc. Common Stock position peaked at $7K in Q3 2018.
  • 14 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2018.

Based on Panagora Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.